Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600119514Phase 4Recruiting
Phase 4, randomised trial in hypertension (HTN) comparing Propofol induction, Ciprofol induction and Remimazolam induction (3 arms). Primary endpoint: General anesthesia-induced hypotension. Started Feb 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600119514.